Reversal of Autoimmunity by Boosting Memory-like Autoregulatory T Cells

Immunity

Volumn 32, Issue 4, 2010, Pages 568-580

  Tsai, Sue ^a,b   Shameli, Afshin ^a,b   Yamanouchi, Jun ^a,b   Clemente Casares, Xavier ^a,b   Wang, Jinguo ^a,b   Serra, Pau ^a,b   Yang, Yang ^a,b   Medarova, Zdravka ^c   Moore, Anna ^c   Santamaria, Pere ^a,b  

^a UNIVERSITY OF CALGARY   (Canada)

^b UNIVERSITY OF CALGARY   (Canada)

^c HARVARD MEDICAL SCHOOL   (United States)

Author keywords

Cellimmuno; Humdisease

Indexed keywords

ANTIDIABETIC AGENT; GAMMA INTERFERON; HERMES ANTIGEN; HLA A2 ANTIGEN; INDOLEAMINE 2,3 DIOXYGENASE; INTERLEUKIN 10; INTERLEUKIN 2; INTERLEUKIN 2 RECEPTOR BETA; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 1; MIMA2 D; MONOCLONAL ANTIBODY CD3; NANOPARTICLE; NRP V7 K; PERFORIN; T LYMPHOCYTE RECEPTOR ALPHA CHAIN; TRANSFORMING GROWTH FACTOR BETA; UNCLASSIFIED DRUG; G6PC2 PROTEIN, MOUSE; GLUCOSE 6 PHOSPHATASE; PROTEIN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIGEN PRESENTATION; ARTICLE; AUTOIMMUNE DISEASE; CD8+ T LYMPHOCYTE; CELL MEDIATED CYTOTOXICITY; CONCENTRATION RESPONSE; CONTROLLED STUDY; CYTOKINE RELEASE; FEMALE; IMMUNOREGULATION; INSULIN DEPENDENT DIABETES MELLITUS; INSULIN RELEASE; LYMPHOCYTE DIFFERENTIATION; MAJOR HISTOCOMPATIBILITY COMPLEX; MEMORY T LYMPHOCYTE; MOUSE; NONHUMAN; PATHOGENESIS; PRIORITY JOURNAL; AMINO ACID SEQUENCE; ANIMAL; AUTOIMMUNITY; CELL DIFFERENTIATION; CHEMISTRY; HUMAN; IMMUNOLOGICAL MEMORY; IMMUNOLOGY; MOLECULAR GENETICS; NONOBESE DIABETIC MOUSE; NUCLEOTIDE SEQUENCE; REGULATORY T LYMPHOCYTE;

AMINO ACID SEQUENCE; ANIMALS; ANTIGEN PRESENTATION; AUTOIMMUNITY; BASE SEQUENCE; CD8-POSITIVE T-LYMPHOCYTES; CELL DIFFERENTIATION; DIABETES MELLITUS, TYPE 1; FEMALE; GLUCOSE-6-PHOSPHATASE; HUMANS; IMMUNOLOGIC MEMORY; INDOLEAMINE-PYRROLE 2,3,-DIOXYGENASE; INTERFERON-GAMMA; MAJOR HISTOCOMPATIBILITY COMPLEX; MICE; MICE, INBRED NOD; MOLECULAR SEQUENCE DATA; PERFORIN; PROTEINS; T-LYMPHOCYTES, REGULATORY;

EID: 77951882989     PISSN: 10747613     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.immuni.2010.03.015     Document Type: Article

References (33)

1. Aichele P., Kyburz D., Ohashi P.S., Odermatt B., Zinkernagel R.M., Hengartner H., Pircher H. Peptide-induced T-cell tolerance to prevent autoimmune diabetes in a transgenic mouse model. Proc. Natl. Acad. Sci. USA 1994, 91:444-448.
2. Amrani A., Verdaguer J., Serra P., Tafuro S., Tan R., Santamaria P. Progression of autoimmune diabetes driven by avidity maturation of a T-cell population. Nature 2000, 406:739-742.
3. Amrani A., Serra P., Yamanouchi J., Trudeau J.D., Tan R., Elliott J.F., Santamaria P. Expansion of the antigenic repertoire of a single T cell receptor upon T cell activation. J. Immunol. 2001, 167:655-666.
4. +) T cell response against one peptide/MHC complex in autoimmune diabetes. Proc. Natl. Acad. Sci. USA 1999, 96:9311-9316.
5. +) T cells produce antiviral cytokines but are impaired in cytolytic function. J. Exp. Med. 2000, 192:63-75.
6. Bachmann M.F., Gallimore A., Linkert S., Cerundolo V., Lanzavecchia A., Kopf M., Viola A. Developmental regulation of Lck targeting to the CD8 coreceptor controls signaling in naive and memory T cells. J. Exp. Med. 1999, 189:1521-1530.
7. Barber D.L., Wherry E.J., Masopust D., Zhu B., Allison J.P., Sharpe A.H., Freeman G.J., Ahmed R. Restoring function in exhausted CD8 T cells during chronic viral infection. Nature 2006, 439:682-687.
8. + Tregs. J. Clin. Invest. 2005, 115:2904-2913.
9. Cernea S., Herold K.C. Monitoring of antigen-specific CD8 T cells in patients with type 1 diabetes treated with antiCD3 monoclonal antibodies. Clin. Immunol. 2010, 134:121-129.
10. Endharti A.T., Rifa'I M., Shi Z., Fukuoka Y., Nakahara Y., Kawamoto Y., Takeda K., Isobe K., Suzuki H. Cutting edge: CD8+CD122+ regulatory T cells produce IL-10 to suppress IFN-gamma production and proliferation of CD8+ T cells. J. Immunol. 2005, 175:7093-7097.
11. + T cells enter reactive lymph nodes and kill dendritic cells. Nat. Immunol. 2007, 8:743-752.
12. Han B., Serra P., Amrani A., Yamanouchi J., Marée A.F., Edelstein-Keshet L., Santamaria P. Prevention of diabetes by manipulation of anti-IGRP autoimmunity: high efficiency of a low-affinity peptide. Nat. Med. 2005, 11:645-652.
13. Han B., Serra P., Yamanouchi J., Amrani A., Elliott J.F., Dickie P., Dilorenzo T.P., Santamaria P. Developmental control of CD8 T cell-avidity maturation in autoimmune diabetes. J. Clin. Invest. 2005, 115:1879-1887.
14. Jiang H., Chess L. How the immune system achieves self-nonself discrimination during adaptive immunity. Adv. Immunol. 2009, 102:95-133.
15. Jürgens B., Hainz U., Fuchs D., Felzmann T., Heitger A. Interferon-gamma-triggered indoleamine 2,3-dioxygenase competence in human monocyte-derived dendritic cells induces regulatory activity in allogeneic T cells. Blood 2009, 114:3235-3243.
16. Kaufman A., Herold K.C. Anti-CD3 mAbs for treatment of type 1 diabetes. Diabetes Metab. Res. Rev. 2009, 25:302-306.
17. Lechner F., Wong D.K., Dunbar P.R., Chapman R., Chung R.T., Dohrenwend P., Robbins G., Phillips R., Klenerman P., Walker B.D. Analysis of successful immune responses in persons infected with hepatitis C virus. J. Exp. Med. 2000, 191:1499-1512.
18. Lieberman S.M., DiLorenzo T.P. A comprehensive guide to antibody and T-cell responses in type 1 diabetes. Tissue Antigens 2003, 62:359-377.
19. + T cells in autoimmune diabetes. Proc. Natl. Acad. Sci. USA 2003, 100:8384-8388.
20. + T cell reactivity to three islet antigens, including the newly identified widely expressed dystrophia myotonica kinase. J. Immunol. 2004, 173:6727-6734.
21. Miller S.D., Wetzig R.P., Claman H.N. The induction of cell-mediated immunity and tolerance with protein antigens coupled to syngeneic lymphoid cells. J. Exp. Med. 1979, 149:758-773.
22. + T-cells to the pancreas in real time. Diabetes 2004, 53:1459-1466.
23. Oh S., Perera L.P., Burke D.S., Waldmann T.A., Berzofsky J.A. IL-15/IL-15Ralpha-mediated avidity maturation of memory CD8+ T cells. Proc. Natl. Acad. Sci. USA 2004, 101:15154-15159.
24. Sallusto F., Geginat J., Lanzavecchia A. Central memory and effector memory T cell subsets: function, generation, and maintenance. Annu. Rev. Immunol. 2004, 22:745-763.
25. Serreze D.V., Johnson E.A., Chapman H.D., Graser R.T., Marron M.P., DiLorenzo T.P., Silveira P., Yoshimura Y., Nathenson S.G., Joyce S. Autoreactive diabetogenic T-cells in NOD mice can efficiently expand from a greatly reduced precursor pool. Diabetes 2001, 50:1992-2000.
26. Sprent J., Tough D.F. T cell death and memory. Science 2001, 293:245-248.
27. Trudeau J.D., Kelly-Smith C., Verchere C.B., Finegood D.T., Santamaria P., Tan R. Prediction of spontaneous autoimmune diabetes in NOD mice by quantification of autoreactive T cells in peripheral blood. J. Clin. Invest. 2003, 111:217-223.
28. Tsai S., Shameli A., Santamaria P. CD8+ T cells in type 1 diabetes. Adv. Immunol. 2008, 100:79-124.
29. Verdaguer J., Yoon J.W., Anderson B., Averill N., Utsugi T., Park B.J., Santamaria P. Acceleration of spontaneous diabetes in TCR-β-transgenic nonobese diabetic mice by β-cell cytotoxic CD8+ T cells expressing identical endogenous TCR-α chains. J. Immunol. 1996, 157:4726-4735.
30. Verdaguer J., Schmidt D., Amrani A., Anderson B., Averill N., Santamaria P. Spontaneous autoimmune diabetes in monoclonal T cell nonobese diabetic mice. J. Exp. Med. 1997, 186:1663-1676.
31. + T cells in autoimmunity. Curr. Opin. Immunol. 2005, 17:624-631.
32. + memory T cells. Immunol. Rev. 2006, 211:146-153.
33. Zajac A.J., Blattman J.N., Murali-Krishna K., Sourdive D.J., Suresh M., Altman J.D., Ahmed R. Viral immune evasion due to persistence of activated T cells without effector function. J. Exp. Med. 1998, 188:2205-2213.